Cargando…

Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS

BACKGROUND: Reactive oxygen species (ROS) are produced in the body during normal metabolism by means of enzymes and non-enzymatic chemical reduction of molecular oxygen. In case of the prevalence of ROS formation over their elimination, highly reactive free radicals can be accumulated and can cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomov, Desislav G., Bocheva, Georgeta, Divarova, Vidka, Kasabova, Lilia, Svinarov, Dobrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857857/
https://www.ncbi.nlm.nih.gov/pubmed/33584135
http://dx.doi.org/10.5937/jomb0-24746
_version_ 1783646527170805760
author Tomov, Desislav G.
Bocheva, Georgeta
Divarova, Vidka
Kasabova, Lilia
Svinarov, Dobrin
author_facet Tomov, Desislav G.
Bocheva, Georgeta
Divarova, Vidka
Kasabova, Lilia
Svinarov, Dobrin
author_sort Tomov, Desislav G.
collection PubMed
description BACKGROUND: Reactive oxygen species (ROS) are produced in the body during normal metabolism by means of enzymes and non-enzymatic chemical reduction of molecular oxygen. In case of the prevalence of ROS formation over their elimination, highly reactive free radicals can be accumulated and can cause multiple damages to the biomolecules and cells. Determination of isoprostanes in biological matrices is most often used to register free radical damage and requires selective, sensitive and specific techniques. METHODS: This study presents the development and validation of the LC-MS/MS method for the determination of 8-iso-Prostaglandin F2α in human plasma utilising a modified liquid-liquid extraction procedure with phase separation. RESULTS: Modified sample preparation procedure assured higher extraction yield, clear separation of organic layer from the plasma water phase and protein precipitates, and better-purified product for instrumental analysis. Linearity was validated in the range 0.1-5.0 µg/L with R2 > 0.996; normalised matrix varied between 86.0% and 108.3%, accuracy ranged from 90.4 % to 113.9% and precision both within runs and between runs was less than 7%. With a run time of 10 min, a throughput of over 50 samples per working day could be performed. CONCLUSIONS: The method meets all the current industrial validation criteria and allows the accurate and precise determination of 8-iso-PGF2α in human plasma at diagnostically significant concentration range.
format Online
Article
Text
id pubmed-7857857
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format MEDLINE/PubMed
spelling pubmed-78578572021-02-12 Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS Tomov, Desislav G. Bocheva, Georgeta Divarova, Vidka Kasabova, Lilia Svinarov, Dobrin J Med Biochem Original Paper BACKGROUND: Reactive oxygen species (ROS) are produced in the body during normal metabolism by means of enzymes and non-enzymatic chemical reduction of molecular oxygen. In case of the prevalence of ROS formation over their elimination, highly reactive free radicals can be accumulated and can cause multiple damages to the biomolecules and cells. Determination of isoprostanes in biological matrices is most often used to register free radical damage and requires selective, sensitive and specific techniques. METHODS: This study presents the development and validation of the LC-MS/MS method for the determination of 8-iso-Prostaglandin F2α in human plasma utilising a modified liquid-liquid extraction procedure with phase separation. RESULTS: Modified sample preparation procedure assured higher extraction yield, clear separation of organic layer from the plasma water phase and protein precipitates, and better-purified product for instrumental analysis. Linearity was validated in the range 0.1-5.0 µg/L with R2 > 0.996; normalised matrix varied between 86.0% and 108.3%, accuracy ranged from 90.4 % to 113.9% and precision both within runs and between runs was less than 7%. With a run time of 10 min, a throughput of over 50 samples per working day could be performed. CONCLUSIONS: The method meets all the current industrial validation criteria and allows the accurate and precise determination of 8-iso-PGF2α in human plasma at diagnostically significant concentration range. Society of Medical Biochemists of Serbia, Belgrade 2021-01-26 2021-01-26 /pmc/articles/PMC7857857/ /pubmed/33584135 http://dx.doi.org/10.5937/jomb0-24746 Text en 2021 Desislav G. Tomov, Georgeta Bocheva, Vidka Divarova, Lilia Kasabova, Dobrin Svinarov, published by CEON/CEES http://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License.
spellingShingle Original Paper
Tomov, Desislav G.
Bocheva, Georgeta
Divarova, Vidka
Kasabova, Lilia
Svinarov, Dobrin
Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS
title Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS
title_full Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS
title_fullStr Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS
title_full_unstemmed Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS
title_short Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS
title_sort phase separation liquid-liquid extraction for the quantification of 8-iso-prostaglandin f2 alpha in human plasma by lc-ms/ms
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857857/
https://www.ncbi.nlm.nih.gov/pubmed/33584135
http://dx.doi.org/10.5937/jomb0-24746
work_keys_str_mv AT tomovdesislavg phaseseparationliquidliquidextractionforthequantificationof8isoprostaglandinf2alphainhumanplasmabylcmsms
AT bochevageorgeta phaseseparationliquidliquidextractionforthequantificationof8isoprostaglandinf2alphainhumanplasmabylcmsms
AT divarovavidka phaseseparationliquidliquidextractionforthequantificationof8isoprostaglandinf2alphainhumanplasmabylcmsms
AT kasabovalilia phaseseparationliquidliquidextractionforthequantificationof8isoprostaglandinf2alphainhumanplasmabylcmsms
AT svinarovdobrin phaseseparationliquidliquidextractionforthequantificationof8isoprostaglandinf2alphainhumanplasmabylcmsms